» Articles » PMID: 33282611

Brain Structure and Function in Recovery

Overview
Journal Alcohol Res
Specialty Psychiatry
Date 2020 Dec 7
PMID 33282611
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Alcohol use disorder (AUD) commonly is associated with compromise in neurobiological and/or neurobehavioral processes. The severity of this compromise varies across individuals and outcomes, as does the degree to which recovery of function is achieved. This narrative review first summarizes neurobehavioral, neurophysiological, structural, and neurochemical aberrations/deficits that are frequently observed in people with AUD after detoxification. Subsequent sections review improvements across these domains during recovery, taking into account modulators of recovery to the extent permitted. Where appropriate, the discussion includes work integrating outcomes across domains, leveraging the strengths of diverse experimental methods. Interventions to ameliorate neurobiological or neurobehavioral deficits do not constitute a primary objective of this review. However, their consideration is a logical inclusion. Therefore, a limited introduction to existing methods is also presented.

Citing Articles

Preliminary evidence for changes in frontoparietal network connectivity in the early abstinence period in alcohol use disorder: a longitudinal resting-state functional magnetic resonance imaging study.

van Oort J, Diazgranados N, George D, Horneffer Y, Schwandt M, Goldman D Front Psychiatry. 2023; 14:1185770.

PMID: 37575566 PMC: 10420071. DOI: 10.3389/fpsyt.2023.1185770.


Cognitive training in recently-abstinent individuals with alcohol use disorder improves emotional stroop performance: Evidence from a randomized pilot trial.

Lewis B, Garcia C, Price J, Schweizer S, Nixon S Drug Alcohol Depend. 2022; 231:109239.

PMID: 34998253 PMC: 9311324. DOI: 10.1016/j.drugalcdep.2021.109239.


Memory impairment in alcohol use disorder is associated with regional frontal brain volumes.

Fama R, Le Berre A, Sassoon S, Zahr N, Pohl K, Pfefferbaum A Drug Alcohol Depend. 2021; 228:109058.

PMID: 34610518 PMC: 8595873. DOI: 10.1016/j.drugalcdep.2021.109058.


From the Editors.

Kelly J, Hagman B Alcohol Res. 2021; 41(1):10.

PMID: 34377619 PMC: 8336783. DOI: 10.35946/arcr.v41.1.10.

References
1.
Durazzo T, Meyerhoff D . Changes of frontal cortical subregion volumes in alcohol dependent individuals during early abstinence: associations with treatment outcome. Brain Imaging Behav. 2019; 14(5):1588-1599. PMC: 6908760. DOI: 10.1007/s11682-019-00089-5. View

2.
Koob G, Mason B, de Witte P, Littleton J, Siggins G . Potential neuroprotective effects of acamprosate. Alcohol Clin Exp Res. 2002; 26(4):586-92. View

3.
BLOMQVIST O, Engel J, Nissbrandt H, Soderpalm B . The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine. Eur J Pharmacol. 1993; 249(2):207-13. DOI: 10.1016/0014-2999(93)90434-j. View

4.
Verplaetse T, Pittman B, Shi J, Tetrault J, Coppola S, McKee S . Effect of Varenicline Combined with High-Dose Alcohol on Craving, Subjective Intoxication, Perceptual Motor Response, and Executive Cognitive Function in Adults with Alcohol Use Disorders: Preliminary Findings. Alcohol Clin Exp Res. 2016; 40(7):1567-76. PMC: 4930423. DOI: 10.1111/acer.13110. View

5.
Le Berre A . Emotional processing and social cognition in alcohol use disorder. Neuropsychology. 2019; 33(6):808-821. PMC: 6711390. DOI: 10.1037/neu0000572. View